Dikora Bulk Drug Private Limited, a active private limited company, was established on 28 December 2017 in Bhusawal, Maharashtra, India. Engaging in industrial chemicals within the chemicals and materials sector, it holds CIN: U24100MH2017PTC303432. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹1.00 Cr.
It upholds a compliant status. Its leadership includes Dineshkumar Purushottam Patel (Director), Komal Vikram Patil (Director), Rohit Dinesh Patel (Director). Past directors included Ishwar Purshotam Patel, Prema Kumar Doddamitta. It holds ₹2.58 Cr open charges and ₹3.88 Cr settled loans. Its latest AGM occurred on 16 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No 29 Midc Area Bhuswal, Bhusawal, Maharashtra, 425201.
U24100MH2017PTC303432
303432
28 December 2017
₹1.00 Cr
₹1.00 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Dikora Bulk Drug Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dineshkumar Purushottam Patel | Director | 28 Dec 2017 | Current |
| Komal Vikram Patil | Director | 28 Dec 2017 | Current |
| Rohit Dinesh Patel | Director | 28 Dec 2017 | Current |
| Pratik Dinesh Patel | Director | 28 Dec 2017 | Current |
| Yogesh Purushottam Patel | Director | 28 Dec 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 21 Oct 2019 | Past |
| Pramod Abcsdd | Other Promoter | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Dikora Bulk Drug Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 2721615.13% increase. The company also saw a substantial improvement in profitability, with a 13.76% increase in profit. The company's net worth observed a substantial decline by a decrease of 88.51%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Dikora Bulk Drug had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹25,800,000.00
₹38,800,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Oct 2024 | Hdfc Bank Limited | ₹2.58 Cr | Open |
| 04 Dec 2018 | State Bank Of India | ₹3.88 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Dikora Bulk Drug, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Dikora Bulk Drug, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dikora Bulk Drug's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge registered on 04 Dec 2018 via Charge ID 100225527 with State Bank Of India was fully satisfied on 16 Jul 2025. was recorded as a recent event.
A charge with Hdfc Bank Limited amounted to Rs. 2.58 Cr with Charge ID 101009720 was registered on 09 Oct 2024. was recorded as a recent event.
Dikora Bulk Drug Private Limited last Annual general meeting of members was held on 16 Sep 2024 as per latest MCA records. was recorded as a recent event.
Dikora Bulk Drug Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
A charge with State Bank Of India of Rs. 3.88 Cr registered on 04 Dec 2018 with Charge ID 100225527 was modified on 02 Mar 2022. was recorded as a recent event.
The activity A charge with State Bank Of India amounted to Rs. 3.88 Cr with Charge ID 100225527 was registered on 04 Dec 2018. was completed.
The CIN of Dikora Bulk Drug Private Limited is U24100MH2017PTC303432.
Dikora Bulk Drug Private Limited is headquartered at Plot No 29 Midc Area Bhuswal, Bhusawal, Maharashtra, 425201.
Dikora Bulk Drug Private Limited was incorporated on 28 December 2017.
The current directors of Dikora Bulk Drug Private Limited are
The primary industry of Dikora Bulk Drug Private Limited is Chemicals And Materials.
Dikora Bulk Drug Private Limited is unlisted.
The authorized capital of Dikora Bulk Drug Private Limited is ₹1.00 Cr, and the paid-up capital is ₹1.00 Cr.
The compliance status of Dikora Bulk Drug Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX